Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-23 Purchase |
2023-02-27 5:14 pm |
Enliven Therapeutics Inc. | ELVN | COMMODORE CAPITAL LP 10% Owner |
622 | $22.07 | $13,723 | 2,178,531 (Indirect) |
View |
| 2023-02-21 Purchase |
2023-02-23 4:05 pm |
IMARA Inc. | IMRA | COMMODORE CAPITAL LP 10% Owner |
31,759 | $5.1481 | $163,498 | 2,872,513 (Indirect) |
View |
| 2023-02-22 Sale |
2023-02-22 8:26 pm |
IMARA Inc. | IMRA | GRAY MICHAEL CFO & COO |
9,856 | $4.67 | $46,028 | 27,610 (Direct) |
View |
| 2023-02-22 Sale |
2023-02-22 8:25 pm |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
32,861 | $4.66 | $153,132 | 87,835 (Direct) |
View |
| 2023-01-30 Sale |
2023-02-01 6:26 pm |
IMARA Inc. | IMRA | GRAY MICHAEL CFO & COO |
3,596 | $3.92 | $14,096 | 37,466 (Direct) |
View |
| 2023-01-30 Sale |
2023-02-01 6:24 pm |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
11,313 | $3.91 | $44,234 | 120,696 (Direct) |
View |
| 2023-01-03 Sale(A) |
2023-01-05 8:03 pm |
IMARA Inc. | IMRA | Leonard Braden Michael 10% Owner |
1,250,000 | $4 | $5,000,000 | 1,997,774 (Indirect Direct) |
View |
| 2023-01-03 Purchase |
2023-01-05 4:43 pm |
IMARA Inc. | IMRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
629,297 | $3.9982 | $2,516,055 | 3,880,021 (Indirect) |
View |
| 2023-01-04 Sale |
2023-01-04 7:49 pm |
IMARA Inc. | IMRA | Leonard Braden Michael 10% Owner |
1,250,000 | $4 | $5,000,000 | 1,997,774 (Indirect Direct) |
View |
| 2022-12-30 Sale |
2022-12-30 5:42 pm |
IMARA Inc. | IMRA | Leonard Braden Michael 10% Owner |
20,000 | $4.04 | $80,800 | 3,247,774 (Indirect Direct) |
View |
| 2022-12-28 Sale |
2022-12-29 6:18 pm |
IMARA Inc. | IMRA | Leonard Braden Michael 10% Owner |
20,000 | $4.04 | $80,800 | 3,267,774 (Indirect Direct) |
View |
| 2022-12-22 Sale |
2022-12-27 09:34 am |
IMARA Inc. | IMRA | Leonard Braden Michael 10% Owner |
50,000 | $4.06 | $203,000 | 3,287,774 (Indirect Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:30 pm |
IMARA Inc. | IMRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
29,899 | $3.8662 | $115,595 | 3,250,724 (Indirect) |
View |
| 2022-10-20 Purchase |
2022-10-24 4:41 pm |
IMARA Inc. | IMRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
85,902 | $3.9209 | $336,812 | 3,220,825 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2023-03-06 5:18 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH 10% Owner |
0 | $0 | 5,798,475 (Indirect) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:55 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Schwab Andrew J. Director |
5,798,475 | $0 | 960,383 (Indirect) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:54 pm |
N/A 2032-08-12 |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
239,056 | $0 | 201,649 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:53 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner |
7,899,572 | $0 | 288,114 (Indirect) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:51 pm |
N/A 2032-08-12 |
Enliven Therapeutics Inc. | ELVN | Bauer Jake Director |
105,078 | $0 | 105,078 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:43 pm |
N/A 2031-08-02 |
Enliven Therapeutics Inc. | ELVN | Derynck Mika K Director |
87,373 | $0 | 87,373 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:35 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Patel Anish Chief Operating Officer |
519,963 | $0 | 519,963 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:34 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
1,550,116 | $0 | 1,550,116 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:33 pm |
N/A 2031-08-02 |
Enliven Therapeutics Inc. | ELVN | Hohl Benjamin Chief Financial Officer |
262,120 | $0 | 262,120 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:33 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO |
1,924,969 | $0 | 837,444 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:32 pm |
N/A 2031-06-17 |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise Chief Medical Officer |
287,084 | $0 | 287,084 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:30 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
7,899,572 | $0 | 288,114 (Indirect) |
View |
| 2023-02-23 Other |
2023-02-27 5:14 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | COMMODORE CAPITAL LP 10% Owner |
729,891 | $0 | 2,178,531 (Indirect) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:31 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Former 10% owner |
1,152,460 | $0 | 2,122,465 (Indirect) |
View |
Ownership |
2023-02-21 4:06 pm |
N/A N/A |
IMARA Inc. | IMRA | COMMODORE CAPITAL LP 10% Owner |
0 | $0 | 2,840,754 (Indirect) |
View |